Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord mesenchymal stem cells (Changhai Hospital)
- Development stage
- Unknown
- Lead developer
- Changhai Hospital
- Modality
- Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Inhalation
01
Overview
Umbilical cord mesenchymal stem cells (UCMSCs) are a cell therapy product being investigated by Changhai Hospital for the treatment of post-acute COVID-19 syndrome (Long COVID) and associated chronic cough. UCMSCs are multipotent stem cells known for their significant immunomodulatory, anti-inflammatory, and tissue-regenerative capabilities. In clinical settings, they are typically administered via intravenous infusion to address systemic inflammation and immune dysregulation. Additionally, the hospital is evaluating UCMSC-derived exosomes—small extracellular vesicles secreted by the cells—delivered via nebulized inhalation to specifically target respiratory symptoms like chronic cough. The therapy aims to restore immune homeostasis and facilitate the repair of damaged tissues in patients suffering from persistent post-viral symptoms.
- Other names
- UCMSCumbilical cord mesenchymal stem cellUC-MSCUCMSC-derived exosomes
Beyond the preview
Go deeper on umbilical cord mesenchymal stem cells (Changhai Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord mesenchymal stem cells (Changhai Hospital).